To include your compound in the COVID-19 Resource Center, submit it here.

India approves Epirus' Remicade biosimilar

The Drug Controller General of India (DCGI) approved manufacturing and marketing of

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE